## NCNO: nCino, Inc. - XLK: Technology

### Executive Summary

VALUE thesis: PEG 0.77 indicates fundamental undervaluation. Consistent execution (3/4 quarters beat estimates).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($22.42)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 8
- **Sentiment:** Bullish (Bullish: 4, Bearish: 0)

**1. HubSpot, nCino, Rapid7, and Health Catalyst Stocks Trade Down, What You Need To Know**
- Source: TradingView â€” Track All Markets | 20251215T200911 | Neutral | Relevance: 100%
- Several tech stocks, including HubSpot, nCino, Rapid7, and Health Catalyst, experienced a downturn following investor concerns that significant AI investments may not yield sufficient profits, sparking fears of an "AI bubble." This sentiment was intensified by Broadcom's warning of thinner profit margins from increased AI system sales, leading to a market recalibration and a rotation of capital out of speculative tech. The article highlights some specific stock movements and discusses nCino's recent stock repurchase program as a sign of management confidence despite the broader market's uncertainty.

**2. nCino (NCNO) Valuation Check After New $100 Million Buyback and Upgraded Earnings Guidance**
- Source: Simply Wall Street | 20251214T020827 | Somewhat-Bullish | Relevance: 100%
- nCino (NCNO) recently announced a new $100 million share repurchase program and upgraded earnings guidance, signaling management confidence despite a negative one-year shareholder return. The company's valuation narrative suggests it is 28.3% undervalued with a fair value of $35.54, driven by platform expansion and cross-sell opportunities. However, its price-to-sales ratio is still higher than peers and the broader software sector, indicating a cautious outlook unless growth meets expectations.

**3. Wall Street Analysts See a 34.26% Upside in nCino (NCNO): Can the Stock Really Move This High?**
- Source: Finviz | 20251213T110911 | Bullish | Relevance: 100%
- nCino (NCNO) shows a potential 34.3% upside according to Wall Street analysts' mean price target of $34.8, despite a recent 1.7% gain over the past four weeks. While analyst price targets can be misleading, a tight clustering of estimates and a strong Zacks Rank #1 (Strong Buy) due to positive earnings estimate revisions suggest potential for the stock. Investors are advised to use price targets as a starting point for research rather than the sole basis for investment decisions.

**4. nCino, Inc. reports strong Q3 earnings and growth**
- Source: MSN | 20251215T111001 | Bullish | Relevance: 100%
- NULL

**5. nCino Inc. $NCNO Stock Holdings Cut by Daventry Group LP**
- Source: MarketBeat | 20251215T101001 | Neutral | Relevance: 100%
- Daventry Group LP significantly reduced its stake in nCino Inc. (NASDAQ:NCNO) by 64.2% in the second quarter, selling 690,347 shares and now owning 384,801 shares valued at $10.76 million. Despite this, other institutions like Vanguard Group and Swiss National Bank increased their holdings, and analysts maintain a "Moderate Buy" consensus rating with an average target price of $33.47. Recent insider selling has also occurred, while nCino reported strong quarterly earnings and initiated a $100 million stock buyback program.

### Analyst Activity

**Target Signal:** BEARISH (Raises: 1, Lowers: 2)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-04 | Truist Securiti | $27 | $32 | -16% |
| 2025-12-04 | Needham | $38 | $38 | 0% |
| 2025-12-04 | Keefe, Bruyette | $36 | $34 | +4% |
| 2025-12-04 | Piper Sandler | $30 | $34 | -12% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-04 | Truist Securiti | main | Hold |
| 2025-12-04 | Needham | reit | Buy |
| 2025-12-04 | Keefe, Bruyette | main | Outperform |
| 2025-12-04 | Piper Sandler | main | Neutral |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 1 ($0.00M) |
| Sells | 6 ($0.81M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 47.9% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 4 / 5 |

**Top Holders:**
- Vanguard Group Inc: 10.4% (+1.7%)
- Kayne Anderson Rudni: 6.1% (-6.3%)
- HMI Capital Manageme: 5.9% (0.0%)
- Capital Internationa: 5.1% (-0.0%)
- Blackrock Inc.: 4.6% (+4.8%)

### Key Risks

1. Elevated short interest (12.3%): bears positioning against stock.
2. Long-term trend broken: trading 8.7% below SMA200.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Share repurchase program provides demand floor and EPS support.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 0.77 indicates undervaluation relative to growth. Balance sheet: low leverage (D/E 0.49). Analyst sentiment negative (2 target cuts vs 1 raises). Institutional flow bullish (4 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $2.8B |
| Beta | 0.53 |
| 52W Range | $18.75 - $36.26 |
| Short Interest | 12.3% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.77 |
| Forward P/E | 23.9 |
| Current P/E | 27.1 |
| YoY Growth | 13.5% |
| EPS Direction | RISING |

### Technicals

MRS_20 strengthening from -1.8% to -0.4% (+1.4% in 5 days), confirming momentum buildup. Below STRENGTH zone by 4.4pp (needs >4.0% for momentum thesis). Below SMA200 (0.91x), long-term trend not supportive. RSI neutral at 46. OFD pattern: -MTL (Decline).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -0.44% (CS: 31) | Neutral |
| RSI_14 | 45.8 | Neutral |
| MACD Histogram | 0.13 | Bullish |
| vs SMA20 | 0.993x | Below |
| vs SMA50 | 0.970x | Below |
| vs SMA200 | 0.913x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $24.52
- **Stop Loss:** $22.42 (8.6% risk)
- **Target:** $28.72 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 476
- **Position Value:** $11,671.52
- **Portfolio %:** 11.67%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderate risk appetite and mixed signals. VIX at moderate levels (16.5) with elevated put/call ratio suggesting cautious positioning, while normal yield curve and stable breadth indicate no systemic stress. Focus on selective opportunities with defensive positioning.*

### Earnings

**Next:** 2026-03-31 (Est: $0.21)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q4 | $0.21 | $0.31 | +49.9% |
| 2025Q3 | $0.14 | $0.22 | +58.1% |
| 2025Q2 | $0.16 | $0.16 | +1.8% |
| 2025Q1 | $0.18 | $0.12 | -34.9% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*